The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA)
Abstract
The tissue response and in vivo molecular stability of injection‐molded polyhydroxyacids—polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA, 5–22% VA content)—were studied. Polymers were implanted subcutaneously in mice and extirpated at 1, 3, and 6 month in order to study tissue response and polymer degradation. All polymers were well tolerated by the tissue. No acute inflammation, abscess formation, or tissue necrosis was observed in tissues adjacent to the implanted materials. Furthermore, no tissue reactivity or cellular mobilization was evident remote from the implant site. Mononuclear macrophages, proliferating fibroblasts, and mature vascularized fibrous capsules were typical of the tissue response. Degradation of the polymers was accompanied by an increase in collagen deposition. For the polylactide series, the inflammatory response after 1 month of implantation was less for materials containing the D‐unit in the polymer chain, whereas in the case of the polyhydroxybutyrate/valerates, the number of inflammatory cells increased with increasing content of the valerate unit in the polymer chain. Between 1–3 months, there was slightly more tissue response to the PHB and PHB/VA polymers than to PLA. This response is attributed to the presence of leachable impurities and a low molecular weight soluble component in the polyhydroxybutyrate/valerates. At 6 months, the extent of tissue reaction was similar for both types of polymers. All polylactides degraded significantly (56–99%) by 6 months. For a poly(L‐lactide) series, degradation rate in vivo decreased with increasing initial molecular weight of the injection‐molded polymer. Several samples showed pronounced bimodal molecular weight distributions (MWD), which may be due to differences in degradation rate, resulting from variability in distribution of crystalline and amorphous regions within the samples. This may also be the result of two different mechanisms, i.e., nonenzymatic and enzymatic, which are involved in the degradation process, the latter being more extensive at the later stage of partially hydrolyzed polymer. The PHB and PHB/VA polymers degraded less (15–43%) than the polylactides following 6 months of implantation. Generally, the polymer with higher valerate content (19%, 22% degraded most. The decrease in molecular weight was accompanied by a narrowing of the MWD for PHB and copolymers; there was no evidence of a bimodal MWD, possibly indicating that the critical molecular weight that would permit enzyme/polymer interaction had not been reached. Weight loss during implantation ranged from 0–50% for the polylactides, whereas for the PHB polymers weight loss ranged from 0–1.6%. © 1993 John Wiley & Sons, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischer, E. W., Sterzel, H. J., & Wegner, G. (1973) · Kolloid-Zeitschrift und Zeitschrift für Polymere · doi:10.1007/bf01498927 · Cited by 1,704
Crystallization and morphology of a bacterial thermoplastic: poly-3-hydroxybutyrate
Barham, P. J., Keller, A., Otun, E. L., & Holmes, P. A. (1984) · Journal of Materials Science · doi:10.1007/bf01026954 · Cited by 1,080
Pitt, G. G., Gratzl, M. M., Kimmel, G. L., Surles, J., & Sohindler, A. (1981) · Biomaterials · doi:10.1016/0142-9612(81)90060-0 · Cited by 857
Polylactic Acid for Surgical Implants
KULKARNI, R. K. (1966) · Archives of Surgery · doi:10.1001/archsurg.1966.01330050143023 · Cited by 841
Biocompatibility of clinical implant materials
Williams, D. F. (1981) · CRC Press eBooks · Cited by 773
Bioresorbability and biocompatibility of aliphatic polyesters
Vert, M., Li, S. M., Spenlehauer, G., & Guerin, P. (1992) · Journal of Materials Science: Materials in Medicine · doi:10.1007/bf00701240 · Cited by 770
Li, S. M., Garreau, H., & Vert, M. (1990) · Journal of Materials Science: Materials in Medicine · doi:10.1007/bf00700871 · Cited by 733
Aliphatic polyesters. I. The degradation of poly(ϵ‐caprolactone) in vivo
Pitt, C. G., Chasalow, F. I., Hibionada, Y. M., Klimas, D. M., & Schindler, A. (1981) · Journal of Applied Polymer Science · doi:10.1002/app.1981.070261124 · Cited by 712
Thermal characterization of polylactides
Jamshidi, K., Hyon, S.-H., & Ikada, Y. (1988) · Polymer · doi:10.1016/0032-3861(88)90116-4 · Cited by 692
Doi, Y., Kanesawa, Y., Kunioka, M., & Saito, T. (1990) · Macromolecules · doi:10.1021/ma00203a006 · Cited by 515
Cited by
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable Polymers-A Review on Recent Trends and Emerging Perspectives
Luckachan, G. E., & Pillai, C. K. S. (2011) · Journal of Polymers and the Environment · doi:10.1007/s10924-011-0317-1 · Cited by 767
Li, S. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(1999)48:3<342::aid-jbm20>3.0.co;2-7 · Cited by 664
Biocompatibility and safety of PLA and its copolymers
Ramot, Y., Haim-Zada, M., Domb, A. J., & Nyska, A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.012 · Cited by 576
Elastomeric biomaterials for tissue engineering
Chen, Q., Liang, S., & Thouas, G. A. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.05.003 · Cited by 564
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone
Thomson, R. C., Yaszemski, M. J., Powers, J. M., & Mikos, A. G. (1996) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856295x00805 · Cited by 493
Li, J., Li, X., Ni, X., Wang, X., Li, H., & Leong, K. W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.025 · Cited by 429
Engineering Bone Regeneration with Bioabsorbable Scaffolds with Novel Microarchitecture
Whang, K., Healy, K. E., Elenz, D. R., Nam, E. K., Tsai, D. C., Thomas, C. H., Nuber, G. W., Glorieux, F. H., Travers, R., & Sprague, S. M. (1999) · Tissue Engineering · doi:10.1089/ten.1999.5.35 · Cited by 405
Resorbable biomaterials as bone graft substitutes
Bohner, M. (2010) · Materials Today · doi:10.1016/s1369-7021(10)70014-6 · Cited by 405
Current applications and future perspectives of artificial nerve conduits
Jiang, X., Lim, S. H., Mao, H.-Q., & Chew, S. Y. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.009 · Cited by 394
Polyhydroxyalkanoate (PHA)/Inorganic Phase Composites for Tissue Engineering Applications
Misra, S. K., Valappil, S. P., Roy, I., & Boccaccini, A. R. (2006) · Biomacromolecules · doi:10.1021/bm060317c · Cited by 372
Biosynthetic polyhydroxyalkanoates and their potential in drug delivery
Pouton, C. W., & Akhtar, S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00092-l · Cited by 369
Present and Future of PLA Polymers
Vert, M., Schwarch, G., & Coudane, J. (1995) · Journal of Macromolecular Science, Part A · doi:10.1080/10601329508010289 · Cited by 365
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Valantin, M.-A., Aubron-Olivier, C., Ghosn, J., Laglenne, E., Pauchard, M., Schoen, H., Bousquet, R., Katz, P., Costagliola, D., & Katlama, C. (2003) · AIDS · doi:10.1097/00002030-200311210-00009 · Cited by 355
Bioactive composite materials for tissue engineering scaffolds
Boccaccini, A. R., & Blaker, J. J. (2005) · Expert Review of Medical Devices · doi:10.1586/17434440.2.3.303 · Cited by 347
Biodegradable polymers for biomedical uses
Hayashi, T. (1994) · Progress in Polymer Science · doi:10.1016/0079-6700(94)90030-2 · Cited by 341
Adverse reactions to injectable soft tissue fillers
Requena, L., Requena, C., Christensen, L., Zimmermann, U. S., Kutzner, H., & Cerroni, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.064 · Cited by 338
A review on PLA-based biodegradable materials for biomedical applications
Hussain, M., Khan, S. M., Shafiq, M., & Abbas, N. (2024) · Giant · doi:10.1016/j.giant.2024.100261 · Cited by 326
Aliphatic Polyesters: Abiotic and Biotic Degradation and Degradation Products
Hakkarainen, M. (2002) · Advances in Polymer Science · doi:10.1007/3-540-45734-8_4 · Cited by 293
Gorrasi, G., & Pantani, R. (2013) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2013.02.005 · Cited by 290
Calcium phosphate bone graft substitutes: Failures and hopes
Bohner, M., Galea, L., & Doebelin, N. (2012) · Journal of the European Ceramic Society · doi:10.1016/j.jeurceramsoc.2012.02.028 · Cited by 256
(2005) · PubMed · Cited by 121
Synthesis of degradable, biocompatible, and tough block‐copolyesterurethanes
Hirt, T. D., Neuenschwander, P., & Suter, U. W. (1996) · Macromolecular Chemistry and Physics · doi:10.1002/macp.1996.021971221 · Cited by 78
Metadata
- Authors
- Gogolewski, S., Jovanovic, M., Perren, S. M., Dillon, J. G., & Hughes, M. K.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 1993-09
- Volume
- 27
- Issue
- 9
- Pages
- 1135-1148
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W2148714283
- Cited by
- 547
- References
- 51
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.